Biomarker Commercialization

Programme 2014 - 2020 INTERREG VB Baltic Sea

Date of latest update: 2023-11-06

Description

Description (EN):

Biomarkers measure cellular, biochemical or molecular changes in human tissues, cells or fluids, and contribute to future diagnostics and treatment. The development of biomarkers is time consuming and expensive, requiring the involvement of industry from early stages to better direct the research. The BIC platform facilitates knowledge and best practice exchange, offering tools that support the various phases of a commercialization process and maturity assessment. BIC challenges: Biomarkers consist of cellular, biochemical or molecular changes measured in tissues, cells or fluids such as blood, muscles, urine or skin. With the help of relevant tools or technologies, biomarkers can predict, diagnose and provide information on an individual’s health, thus contributing to the development of personalised medicine. Biomarkers’ discovery form a large potential for new markets, for both researchers, enterprises and small and medium sized enterprises (SMEs). However, among the research institutions there is general lack of experience of how to bring biomarkers through the innovation processes and into the use in clinical practices. Furthermore, the challenges for market uptake of these innovations are significant, as the development and commercialization of biomarkers is time consuming, difficult and expensive. Aim of BIC project: BIC develops a platform that provides new tools to support the different phases of a new commercialization process, assessing the maturity level and emphasising the industry expectations. By enabling better and more efficient commercialization of biomarkers, BIC contributes to improving realisation and competitiveness of biomarkers discoveries, and in a long term, it will benefit hospitals and patients. BIC results : The expected results are to create: a Biomarker Development Tool; a Screening and Selection Guide; a Framework for Technology Translation into clinical setting; new Business Model Templates; a Biomarker Platform with access to the tools and technology presentations for match making between industry and researchers. The commercialization tools are tested, verified and adjusted in at least nine pilots based on current biomarker projects among the partnership.

Achievements (EN):

The project has established strong links with the Technology Transfer Offices, clusters and technology parks, researchers and small and medium sized enterprises (SMEs) outside the partnership and has triggered their interest in the tools in development. The project is proceeding well with the development of a set of tools called the “BiC Master Tool”. The Tool addresses professionals working in the discovery and commercialisation of biomarkers and guides them through the different steps needed to commercialise a biomarker. The partners organised a first series of workshops in Denmark and Finland to test and review first versions of the tool and to acquire knowledge from the professionals who will be using it. The project also compiled a handbook with best practices and obstacles in the biomarker development, as well as patent protection (intellectual rights) and technology transfer aspects. Follow-up activities: The BIC project ended in September 2020 with a final webinar marking the launch of the BIC toolset and continues as BiC Bridge project. http://interreg-baltic.eu/project/bic/

Website: https://biomarker.nu/

Delivered Outputs (EN): POSSIBILITIES AND LIMITATIONS IN LEGISLATION BiC MASTER TOOL VALIDATED BIOMARKER DEVELOPMENT TOOL VALIDATED SCREENING AND SELECTION GUIDE VALIDATED BUSINESS MODEL TEMPLATES

Thematic information

Health and social services New products and services

Specific Objective: ‘Non-technological innovation’: To advance the Baltic Sea Region performance in non-technological innovation based on increased capacity of innovation actors

Thematic Objective: (01) strengthening research, technological development and innovation by:

Investment Priority:

(01b) promoting business investment in R&I, developing links and synergies between enterprises, research and development centres and the higher education sector, in particular promoting investment in product and service development, technology transfer, social innovation, eco-innovation, public service applications, demand stimulation, networking, clusters and open innovation through smart specialisation, and supporting technological and applied research, pilot lines, early product validation actions, advanced manufacturing capabilities and first production, in particular in key enabling technologies and diffusion of general purpose technologies

Partners (9)

Lead Partner: Ideklinikken, Aalborg Universitetshospital, Region Nordjylland

Department: The Ideas Clinic

Address: Forskningen Hus, Sdr. Skovvej 15, 9000 Aalborg , Denmark

Legal status: public

Website: http://www.ideklinikken.rn.dk

Total budget: EUR 806 405.84

ERDF budget: EUR 604 804.38

Københavns universitet

Name: Københavns universitet

Department: Biopeople, Denmark’s Life Science Cluster

Address: Biopeople, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark

Legal status: public

Website (not verified): http://www.biopeople.dk

Total budget: EUR 298 500.00

ERDF budget: EUR 223 875.00

Tartu Biotehnoloogia Park OÜ

Name: Tartu Biotehnoloogia Park OÜ

Address: Tiigi 61b, 50410 Tartu, Estonia

Legal status: private

Website: http://www.biopark.ee

Total budget: EUR 164 700.00

ERDF budget: EUR 139 995.00

Turun yliopisto

Name: Turun yliopisto

Department: Innovation Services

Address: YLIOPISTONMÄKI, 20014 Turku, Finland

Legal status: public

Website: http://www.utu.fi

Total budget: EUR 224 650.00

ERDF budget: EUR 168 487.50

Turku Science Park Oy Ab

Name: Turku Science Park Oy Ab

Address: Joukahaisenkatu 3-5 A, 20520 Turku, Finland

Legal status: public

Website: http://www.turkusciencepark.com

Total budget: EUR 337 214.41

ERDF budget: EUR 252 910.80

ScanBalt, WITHDRAWAL (01/07/2019)

Name: ScanBalt, WITHDRAWAL (01/07/2019)

Address: Allegade 14, 4tv c/o Frank, 2000 Frederiksberg, Denmark

Legal status: public

Website: http://www.scanbalt.org

Total budget: EUR 58 001.11

ERDF budget: EUR 43 500.83

BioCon Valley® GmbH

Name: BioCon Valley® GmbH

Department: BioCon Valley® GmbH

Address: Walther-Rathenau-Straße 49a, 17489 Greifswald, Germany

Legal status: private

Website: http://www.bioconvalley.org

Total budget: EUR 232 550.00

ERDF budget: EUR 174 412.50

Vilniaus Universitetas

Name: Vilniaus Universitetas

Department: Intellectual Property Management and Commercialization Office

Address: 3 Universiteto st., 01513 Vilnius, Lithuania

Legal status: public

Website: http://www.vu.lt

Total budget: EUR 81 142.58

ERDF budget: EUR 68 971.19

Wrocławski Park Technologiczny S.A.

Name: Wrocławski Park Technologiczny S.A.

Department: Department of Investment, Research & Development

Address: Muchoborska 18, , 54-424 Wrocław, Poland

Legal status: public

Website: http://www.technologpark.pl

Total budget: EUR 182 994.25

ERDF budget: EUR 155 545.11

Partners map

Partners and Projects info

Ideklinikken, Aalborg University Hospital, The North Denmark Region

Biomarker Commercialization

Partners and Projects info

University of Copenhagen

Biomarker Commercialization

Partners and Projects info

Tartu Biotechnology Park

Biomarker Commercialization

Partners and Projects info

University of Turku

Biomarker Commercialization

Partners and Projects info

Turku Science Park Ltd

Biomarker Commercialization

Partners and Projects info

ScanBalt, WITHDRAWAL (01/07/2019)

Biomarker Commercialization

Partners and Projects info

BioCon Valley® GmbH

Biomarker Commercialization

Partners and Projects info

Vilnius University

Biomarker Commercialization

Partners and Projects info

Wroclaw Technology Park

Biomarker Commercialization

Lead partner

Project partner

Summary

Project name (EN): Biomarker Commercialization

Project acronym: BIC

Project start date: 2017-10-01

Project end date: 2020-09-30

Project status: closed

Total budget/expenditure: EUR 2 386 158.19

Total EU funding (amount): EUR 1 832 502.31

Total EU funding (co-financing rate): 76.80%

Co-financing sources:

ERDF: Amount, EUR 1 832 502.31.

Documents

Documents on this project are listed below, and organised by category. Please note field "Data source", attached to each document. Keep.eu users are free to use these documents as long as they mention the data source and keep.eu.

Websites / webtools / webforums / cooperative platforms

Biomarker Commercialization - Interreg Baltic Sea Region

Attachment type: link

Type of document: Website / webtool / webforum / cooperative platform

Data source: https://projects.interreg-baltic.eu/

Publication date: 2022-07-29

Document date: 2019-09-30

Languages: en

Attachment link: https://interreg-baltic.eu/project/bic/

IVDR Roadmap

Attachment type: link

Type of document: Website / webtool / webforum / cooperative platform

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2019-09-30

Languages: en

Attachment link: https://prezi.com/view/HfkYvJCSUr4HTin1RsbZ/

Brochures / magazines / manuals

The Biomarker Commercialization (BIC) Guide - For in vitro diagnostics

Attachment type: file

Type of document: Brochure / magazine / manual

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-09-30

Languages: en

Attachment file: Download

Best Practices and Pitfalls in Commercializing - IVD-Applicable Biomarkers

Attachment type: file

Type of document: Brochure / magazine / manual

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2020-06-20

Languages: en

Attachment file: Download

Biomarker Commercialization Review Tool

Attachment type: file

Type of document: Brochure / magazine / manual

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2019-09-30

Languages: en

Attachment file: Download

BIC Regulatory Guide - In vitro diagnostics

Attachment type: file

Type of document: Brochure / magazine / manual

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-09-30

Languages: en

Attachment file: Download

BIC Flowchart

Attachment type: file

Type of document: Brochure / magazine / manual

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2019-09-30

Languages: en

Attachment file: Download

Videos / films

IN FOCUS: Biomarker Commercialization Guide – Go-to-Market Phases

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-09-27

Languages: en

EATRIS BIC BRIDGE Webinar on the biomarker commercialisation process for Technology Transfer Offices

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-06-11

Languages: en

The BIC Biomarker Commercialization Project

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-03-22

Languages: en

Webinar on How to Commercialize your Biomarker Discovery #3

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2020-09-25

Languages: en

Webinar "How to Commercialise your Biomarker Discovery #1"

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2020-06-04

Languages: en

EATRIS BIC BRIDGE Webinar on the biomarker commercialisation process for Technology Transfer Offices

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-06-11

Languages: en

BIC Tools (longer version)

Attachment type: link

Type of document: Video / film

Data source: " 31 views2 Dec 2020" https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2020-12-02

Languages: en

BIC testimonials

Attachment type: link

Type of document: Video / film

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-01-26

Languages: en

Presentations

Online Seminar - The European In-Vitro Diagnostics Regulation

Attachment type: file

Type of document: Presentation

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-05-11

Languages: en

Attachment file: Download

The European In Vitro Diagnostics Regulation

Attachment type: file

Type of document: Presentation

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-05-11

Languages: en

Attachment file: Download

BiC Bridge – Introduction to regulatory tools

Attachment type: file

Type of document: Presentation

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2021-05-11

Languages: en

Attachment file: Download

#FactFriday

Attachment type: file

Type of document: Presentation

Data source: https://biomarker.nu/

Publication date: 2022-07-29

Document date: 2019-09-30

Languages: en

Attachment file: Download

Information regarding the data in keep.eu on the programme financing this project

Financing programme

2014 - 2020 INTERREG VB Baltic Sea

Last month that data in keep.eu was retrieved from the Programme's website or received from the Programme

2023-06-16

No. of projects in keep.eu / Total no. of projects (% of projects in keep.eu)

200 / 200 (100%)

No. of project partnerships in keep.eu / Total no. of project partnerships (% of project partnerships in keep.eu)

2 025 / 2 025 (100%)

Notes on the data

Information provided by the Programme. Achievements were retrieved by Interact from the Programme website (http://www.interreg-baltic.eu/home.html), or a website directly linked from it, on 2021-11-30.

Languages

Contact Form

Biomarker Commercialization

Description

Thematic information

Partners (9)

Partners map

Summary

Documents

Information regarding the data in keep.eu on the programme financing this project

Disclaimer